HIkmate Abriouel | Microbiology | Best Researcher Award 

Prof. HIkmate Abriouel | Microbiology | Best Researcher Award 

 Professor at University of Jaén ,Spain

Dr. Hikmate Abriouel is a distinguished Full Professor of Microbiology at the University of Jaén, Spain. With a PhD in Biological Sciences, she is a globally recognized researcher, featured in Stanford’s Top 2% Scientists list (2021–2024). Her academic career is marked by leadership in microbiological research and education. She leads the “Microbiology and Health” group, focusing on antimicrobial resistance and probiotics of vegetable origin. Currently serving as Vice-Rector of Official Education at the University of Jaén, she has contributed significantly to curriculum reform, including the implementation of the Medicine degree. Dr. Abriouel is deeply involved in international research collaborations, has mentored numerous PhD scholars, and is known for her strong commitment to science communication and outreach. Her scholarly work includes over 160 indexed articles and several editorial roles. She remains an influential figure in advancing microbiology through an inclusive, multidisciplinary, and globally connected research approach.

🔹Professional Profile 

🏆Strengths for the Award

  1. Outstanding Academic Record

    • PhD in Biological Sciences, extensive postdoctoral international training.

    • Over 160 indexed publications, with a Scopus h-index of 51 and 9400+ citations, reflecting sustained and influential scholarly output.

  2. Global Recognition

    • Consistently featured in Stanford’s Top 2% Scientists (2021–2024).

    • Recognized as a Highly Cited Researcher, indicating international impact.

  3. Research Leadership and Innovation

    • Leads the “Microbiology and Health” research group with a focus on AMR, probiotics, and One Health approaches.

    • 27 funded national and international research projects, many with cross-disciplinary and applied relevance.

    • Holds patents, showcasing translation of science into practical applications.

  4. Educational Contributions

    • Vice-Rector of Official Education at the University of Jaén.

    • Played a key role in launching the Medicine degree, driving academic reform.

    • Mentored over 12 PhD scholars, promoting the next generation of microbiologists.

  5. Knowledge Transfer & Industry Collaboration

    • Involved in 12 industry-partnered research contracts, bridging academia and the private sector.

    • Research has direct relevance to public health, food safety, agriculture, and biotechnology.

  6. Editorial and Community Engagement

    • Guest editor for top journals (e.g., Microorganisms, IJMS).

    • Active in science communication and promoting inclusive, multidisciplinary collaboration.

Education 

Dr. Hikmate Abriouel earned her PhD in Biological Sciences, laying a strong foundation for her career in microbiology. Her academic journey reflects a deep commitment to interdisciplinary and impactful scientific work. Her training involved in-depth exposure to microbiological sciences, biotechnology, and public health, particularly in food microbiology and antimicrobial resistance. Throughout her studies, Dr. Abriouel pursued advanced methodologies and scientific inquiry that would later define her contributions to the field. She enhanced her academic profile through research stays in Germany and France, gaining international perspectives on microbiological and public health challenges. These experiences enriched her approach to research, particularly in integrating laboratory-based microbiology with real-world applications. She continues to contribute to higher education as a professor and university leader, advocating for innovative learning models and curriculum reforms. Her educational background, bolstered by continuous learning and global academic exposure, plays a vital role in shaping her as a leader in microbiology and public health.

Professional Experience 

Dr. Hikmate Abriouel has over two decades of academic and research experience in microbiology. As a Full Professor at the University of Jaén, she leads the “Microbiology and Health” research group, specializing in antimicrobial resistance, probiotics, and One Health strategies. Her research spans 27 national and international projects, and she has collaborated with leading scientists across Europe. She also serves as Vice-Rector of Official Education, where she has played a transformative role in modernizing educational programs, notably initiating the university’s Medicine degree. Her experience includes consultancy through 12 industry-partnered research contracts under the university’s Knowledge Transfer Plan. In addition to her research and administrative duties, Dr. Abriouel has mentored more than 12 doctoral students and serves as guest editor for international scientific journals. Her work bridges academic research, industrial applications, and educational leadership, making her a prominent figure in shaping microbiological sciences at both institutional and international levels.

Awards and Honors

Dr. Hikmate Abriouel’s contributions have earned her numerous recognitions. She is featured among the world’s Highly Cited Researchers and listed in Stanford’s prestigious Top 2% Scientists (2021–2024). In acknowledgment of her scientific stature, she is a Permanent Member of the Royal Academy of Veterinary Sciences of Eastern Andalusia. Her scholarly excellence is reflected in her impressive citation record, with an h-index of 51 and over 9400 citations in Scopus, positioning her among the most influential microbiologists globally. She has also served as a guest editor for renowned journals such as International Journal of Molecular Sciences and Microorganisms, further validating her academic influence. She has received competitive research grants and recognition for industry-related knowledge transfer through her work with private-sector collaborations. Her leadership in university governance and public health research continues to attract accolades, positioning her as a key opinion leader in microbiology, public health, and higher education innovation.

Research Focus on Microbiology

Dr. Hikmate Abriouel’s research centers on critical areas of microbiology with global health implications. Her primary focus lies in antimicrobial resistance (AMR), where she explores resistance mechanisms at the phenotypic and genotypic levels, especially in the food chain. She integrates this research within the broader “One Health” framework, promoting a holistic approach to human, animal, and environmental health. She also pioneers studies in vegetable-origin probiotics, particularly from fermented olives, exploring their potential in promoting gut health. Another significant area of her work addresses the antimicrobial activity of substances against plant pathogens such as Xylella fastidiosa and Verticillium dahliae. She has published a patented surface disinfectant and has two more patents under process. Her contributions align with UN Sustainable Development Goals, notably Goal 2 (Zero Hunger) and Goal 12 (Responsible Consumption). Her research not only deepens scientific understanding but also contributes practical solutions for food safety, agriculture, and public health.

📚 Publications Top Notes

Co-cultures of lactic acid bacteria from Brazilian foods as inhibitors of Listeria monocytogenes and Escherichia coli O157:H7 biofilm formation

Authors: [Names not provided]
Journal: Heliyon (2025)
Summary:
This study investigates how combinations of lactic acid bacteria (LAB) isolated from traditional Brazilian foods can inhibit biofilm formation of dangerous pathogens like Listeria monocytogenes and E. coli O157:H7. The results suggest a natural, food-origin microbial solution for controlling biofilms in food safety.

Antimicrobial activity of environmental Bacillus spp. and Peribacillus spp. isolates linked to surfactin, fengycin, bacillibactin and lantibiotics

Authors: [Names not provided]
Journal: International Journal of Biological Macromolecules (2025)
Summary:
This paper examines the antimicrobial potential of environmental strains of Bacillus and Peribacillus, focusing on secondary metabolites like surfactin, fengycin, and lantibiotics. These compounds demonstrate promising bioactivity against pathogens, highlighting their value in biotechnology and natural antimicrobial development.

Transcriptomic analysis of sub-MIC Eugenol exposition on antibiotic resistance profile in Multidrug Resistant Enterococcus faecalis E9.8

Authors: [Names not provided]
Journal: Microbiological Research (2025)
Summary:
This study analyzes how exposing MDR Enterococcus faecalis to sub-inhibitory concentrations of eugenol affects its gene expression, especially related to antibiotic resistance. The transcriptomic data provide insights into the adaptive mechanisms of bacterial resistance and the potential of natural compounds like eugenol in controlling it.

A microalgae Picochlorum sp. AZL19 from Moroccan Mediterranean as a novel source of antioxidant compounds

Authors: [Names not provided]
Journal: Algal Research (2025)
Summary:
The research explores a newly isolated strain of Picochlorum microalgae from the Moroccan Mediterranean coast, emphasizing its production of antioxidant compounds. Findings support its potential in nutraceutical and cosmetic applications due to its bioactive properties.

Impact of disinfection methods used in the slaughterhouse environment on microbiome diversity throughout the meat production chain

Authors: [Names not provided]
Journal: Current Research in Microbial Sciences (2025)
Summary:
This article evaluates how various disinfection techniques in slaughterhouses influence the microbial diversity along the meat supply chain. The research underlines the need for microbiome-conscious disinfection strategies that balance hygiene with microbial ecosystem preservation.

Phenotypic and Genomic Insights Into Bacillus spp. and Peribacillus spp. of Spanish Olive Groves With Biotechnological Potential

Authors: [Names not provided]
Journal: Environmental Microbiology Reports (2024)
Summary:
The study combines phenotypic and genomic approaches to characterize Bacillus and Peribacillus species from olive grove soils in Spain. It highlights their potential in agricultural biotechnology, especially in biocontrol and plant growth promotion.

Exploring synergistic effects of essential oil compounds with antibiotics and biocides against multidrug-resistant foodborne pathogens

Authors: [Names not provided]
Journal: Applied Food Research (2024)
Summary:
This research investigates how combining essential oil components with traditional antibiotics and biocides can enhance antimicrobial efficacy against MDR foodborne pathogens. It supports the potential for integrated natural-synthetic antimicrobial strategies in food safety.

Corrigendum to “Virulence factors, antibiotic resistance, and bacteriocins in enterococci from artisan foods of animal origin”

Authors: [Names not provided]
Original Journal: Food Control (2009)
Summary:
This corrigendum addresses errors in the previously published article about enterococci strains from artisanal foods, focusing on virulence, resistance, and bacteriocin profiles. It ensures accuracy and clarity in the historical scientific record.

Dual effects of a bacteriocin-producing Lactiplantibacillus pentosus CF-6HA, isolated from fermented aloreña table olives, as potential probiotic and antimicrobial agent

Authors: [Names not provided]
Journal: Heliyon (2024)
Summary:
The article presents a strain of L. pentosus from olives with dual functionality—offering probiotic benefits and antimicrobial properties via bacteriocin production. It could serve both as a dietary supplement and a natural preservative.

Antimicrobial profile of the culturable olive sporobiota and its potential as a source of biocontrol agents for major phytopathogens in olive agriculture

Authors: [Names not provided]
Journal: Pest Management Science (2024)
Summary:
This study characterizes spore-forming microbes from olives and examines their antimicrobial activity against key phytopathogens. The results suggest that olive-associated sporobiota can be tapped for sustainable biocontrol in olive cultivation.

Conclusion 

Dr. Hikmate Abriouel exemplifies the blend of academic excellence, impactful research, and leadership in higher education. Her career spans advanced research in microbiology, dedication to combating global health threats like antimicrobial resistance, and a strong focus on food safety and sustainability. As a mentor and educator, she has shaped the careers of future scientists while playing a strategic role in enhancing medical education at the University of Jaén. Her interdisciplinary collaborations, both within Spain and internationally, reflect her ability to foster innovation through partnership. Recognition as a Highly Cited Researcher and her position in Stanford’s Top 2% Scientists underline the global impact of her work. Through her patented innovations, extensive publications, and academic governance, she continues to contribute meaningfully to both science and society. Dr. Abriouel’s career reflects a lifelong commitment to advancing microbiological science while supporting education, innovation, and inclusive scientific communication across local and global communities.

 

Anish Maskey | Immunology and Microbiology | Best Researcher Award

Dr. Anish Maskey | Immunology and Microbiology | Best Researcher Award

Postdoctoral Fellow at New York Medical College, United States

Dr. Anish R. Maskey is a dedicated postdoctoral fellow at the Department of Pathology, Microbiology & Immunology at New York Medical College, with a specialized focus on allergy, immunology, and infectious diseases. With an in-depth understanding of translational research, he integrates bench-to-bedside approaches, concentrating on biomarker discovery, immune response profiling, and therapeutic evaluation for allergic and inflammatory conditions. Over the past six years, he has built a strong scientific portfolio in both academic and clinical research settings, with active involvement in designing, executing, and analyzing preclinical studies using in-vitro systems, human samples, and murine models. His collaborative nature and leadership skills are evident through his mentorship of over 25 trainees, active role in multi-institutional conferences, and contribution to peer-reviewed journals. Dr. Maskey’s publication record includes multiple first-author and collaborative studies in prominent journals like Frontiers in Allergy, Cells, and The Journal of Inflammation Research. His scientific acumen is matched by his commitment to education and community-building in science. As a member of multiple professional societies and editorial boards, he continues to shape the future of immunological research while fostering international collaboration and integrative medical approaches. His work represents a blend of scientific excellence, innovation, and societal impact.

Professional Profile

Education

Dr. Anish R. Maskey holds a Ph.D. in Pathology, Microbiology, and Immunology from New York Medical College, which he earned in 2023 with a commendable CGPA of 3.75/4. His doctoral research was centered on discovering small molecule compounds—particularly from Traditional Chinese Medicine—as novel therapeutics for eosinophilic esophagitis. This body of work laid the foundation for his expertise in allergic diseases, immunomodulation, and translational medicine. Prior to his Ph.D., Dr. Maskey completed his Bachelor of Science in Medical Laboratory Technology from the Institute of Medicine in Kathmandu, Nepal, graduating in 2016 with a strong academic record of 72%. His educational journey reflects a continual evolution from clinical laboratory sciences to cutting-edge immunological research, underpinned by rigorous training in microbiology, molecular biology, and clinical diagnostics. Beyond formal education, he has also actively pursued professional development through certifications in clinical trial ethics, laboratory safety, peer reviewing, and biomedical research compliance under platforms such as CITI and Elsevier. These educational milestones not only showcase Dr. Maskey’s technical proficiency but also his commitment to lifelong learning, scientific integrity, and the ethical conduct of human and animal research. His academic background enables him to operate seamlessly at the intersection of clinical science and laboratory innovation.

Professional Experience

Dr. Maskey currently serves as a postdoctoral fellow at New York Medical College, where he works under the mentorship of Dr. Xiu-Min Li on multiple NIH-funded projects related to allergic diseases, microbiome therapy, and drug discovery. He is the Co-Investigator or Co-Principal Investigator on several high-impact translational research studies involving human clinical samples and murine models. His work explores the therapeutic efficacy of natural compounds on conditions such as eczema, food allergies, eosinophilic esophagitis, and antibiotic-resistant infections. Previously, during his Ph.D. candidacy (2018–2023), he led key investigations on chronic inflammatory diseases and mentored junior researchers while also teaching advanced immunology and microbiology courses. Dr. Maskey has authored or co-authored over 15 peer-reviewed publications and actively contributes as an editorial board member and peer reviewer for journals such as Frontiers in Allergy and The FASEB Journal. In his leadership roles, he has managed research teams, coordinated research conferences, and overseen protocol development and compliance for IRB and IACUC projects. His professional experience reflects a dynamic integration of teaching, research, mentorship, and administration, underlining his preparedness for independent academic or industry-based scientific leadership roles in immunology, microbiology, and translational medicine.

Research Interests

Dr. Anish R. Maskey’s research interests span allergy and immunology, host-pathogen interactions, microbiome-based therapy, and immune modulation using natural compounds. His primary focus lies in discovering and validating biomarkers for allergic diseases, including food allergies, eczema, eosinophilic esophagitis, and drug-resistant infections. Dr. Maskey is particularly interested in translational and integrative approaches to treating chronic inflammation by bridging clinical medicine with basic science. Through his ongoing work on immune profiling, he explores cytokine signaling, IgE-mediated hypersensitivity, mast cell activation, and epigenetic regulation of Th2 responses. He has established various murine models for food allergies, eczema, and Staphylococcus aureus infections to test the efficacy and mechanisms of plant-based therapeutics like berberine and ganoderic acid. Additionally, he investigates the skin and gut microbiomes’ roles in disease progression and recovery, utilizing both in-vivo and ex-vivo models. His interest also extends to nanoparticle drug delivery and immune memory formation. Dr. Maskey’s ultimate goal is to facilitate the development of safer, non-steroidal treatment options that are effective, personalized, and rooted in natural product pharmacology. His work contributes meaningfully to both the scientific community and clinical practice, offering promising alternatives for managing and preventing allergic and inflammatory disorders.

Awards and Honors

Dr. Anish R. Maskey has been the recipient of numerous prestigious awards and honors recognizing his academic excellence, innovative research, and impactful scientific contributions. He has won multiple travel scholarships from the American Academy of Allergy, Asthma & Immunology (AAAAI) from 2022 to 2025, allowing him to present his research at major national conferences. In 2023, he received the APFED travel grant and earned the Outstanding Abstract Award at Touro Research Day in 2024. He also secured second place for oral abstract presentation at the 1st PMI Conference at New York Medical College and was a runner-up in the ASBMB’s “Science in a Flash” competition. His publications have gained recognition as Top Cited and Top Downloaded articles by WILEY and The FASEB Journal. Furthermore, Dr. Maskey has been appointed as an Editorial Board Member for the International Journal of Infectious Diseases and Therapy and The FASEB Journal’s Early Career Researcher Board. His service as a peer reviewer for journals under Cell Press, Frontiers, MDPI, and Dove Medical Press further underscores his credibility and scientific leadership. These accolades collectively affirm his rising influence in the fields of immunology and translational medicine.

Conclusion

Dr. Anish R. Maskey is an outstanding candidate for the Best Researcher Award, especially in the category of early-career/postdoctoral researchers. His contributions to the fields of immunology and infectious diseases are substantive, innovative, and multidisciplinary. His leadership in research, commitment to mentoring, and active scholarly engagement make him exceptionally deserving of recognition.

Publications Top Notes

  • Title: A small molecule compound berberine as an orally active therapeutic candidate against COVID‐19 and SARS
    First Author: Wang ZZ
    Year: 2021
    Citations: 68

  • Title: Cytochrome P450 3A4 suppression by epimedium and kaempferol leads to synergistic anti-inflammatory effect with corticosteroid
    First Author: Li K
    Year: 2023
    Citations: 12

  • Title: Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and berberine with immunometabolism regulation
    First Author: Yang N
    Year: 2023
    Citations: 11

  • Title: Induction of severe eosinophilic esophagitis and multi-organ inflammation by airborne allergens
    First Author: Maskey A
    Year: 2022
    Citations: 9

  • Title: Formononetin inhibits B cell-IgE production by regulating XBP-1
    First Author: Yang N
    Year: 2023
    Citations: 7

  • Title: Anti-IgE effect of arctigenin on food allergy with a distinct transcriptome profile
    First Author: Cao M
    Year: 2022
    Citations: 6

  • Title: Computational analysis of 7,4’-Dihydroxyflavone on eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 3

  • Title: Efficacy of Ganoderic Acid C1 on corticosteroid-resistant neutrophilic airway inflammation
    First Author: Wang ZZ
    Year: 2024
    Citations: 2

  • Title: Berberine inhibits inflammatory response by S. aureus in atopic eczema
    First Author: Maskey AR
    Year: 2024
    Citations: 2

  • Title: Potency and chemical consistency of FAHF-2 for food allergy treatment
    First Author: Maskey A
    Year: 2020
    Citations: 2

  • Title: The gut microbiome and cross-reactivity of food allergens
    First Author: Taico Oliva C
    Year: 2025
    Citations: 1

  • Title: Preclinical models of atopic dermatitis for therapeutic investigations
    First Author: Maskey AR
    Year: 2024
    Citations: 1

  • Title: Berberine’s potential in attenuating S. aureus-induced inflammation
    First Author: Kwan M
    Year: 2024
    Citations: 1

  • Title: 7,4 Dihydroxy Flavone for treatment of eosinophilic esophagitis
    First Author: Maskey AR
    Year: 2022
    Citations: 1

  • Title: Biomarkers and neurobiomarkers in allergic contact dermatitis
    First Author: Sasaki A
    Year: 2025
    Citations: Not listed

  • Title: Roles of bitter and sweet taste receptors in food allergy
    First Author: Xian M
    Year: 2025
    Citations: Not listed

 

Vikram Kumar | Microbiology | Best Research Article Award

Dr. Vikram Kumar | Microbiology | Best Research Article Award

Assistant professor, SRM University Delhi-NCR Sonepat Haryana, India

Profile

Google Scholar

Short Bio 🧑‍🔬

Dr. Vikram is a dedicated microbiologist with a Ph.D. from NIFTEM-K, Sonepat. His research primarily focuses on riboflavin-producing probiotic strains and their applications in food safety and health. With a robust academic foundation and extensive publication record, Dr. Vikram aims to advance the fields of microbiology and biotechnology through innovative research and collaborative efforts.

Education 🎓

Dr. Vikram completed his Ph.D. in Microbiology from NIFTEM-K, Sonepat, in 2024, achieving a CGPA of 6.7. He holds an M.Sc. in Microbiology from Maharshi Dayanand University, Rohtak, where he earned 7.89. Prior to that, he obtained a B.Sc. in Microbiology from the University of Delhi with a percentage of 67%. His academic journey laid a strong foundation for his research in microbial technology and applications.

Experience 💼

Dr. Vikram has served as a mentor for two M.Tech. students, guiding their projects on encapsulation techniques and probiotic development. His hands-on experience with microbiological and molecular techniques equips him with the skills necessary for impactful research. Dr. Vikram’s commitment to teaching and mentorship highlights his dedication to fostering the next generation of scientists in the field of microbiology.

Research Interests 🔬

Dr. Vikram’s research interests include microbiological techniques, probiotic development, and the applications of riboflavin-producing strains in food technology. He is particularly passionate about exploring the potential of probiotics in enhancing food safety and health benefits through innovative biotechnological solutions.

Awards 🏆

Dr. Vikram has been recognized for his academic excellence and research contributions. His work has been pivotal in advancing knowledge in the field of microbiology, and he continues to strive for innovation and improvement in his research methodologies. He aims to further his impact by receiving the “Best Scholar Award,” which would recognize his dedication and achievements.

Publications Top Notes 📚

Dr. Vikram has authored and co-authored numerous publications in reputable journals. Here are some notable works:

  1. Kumar, V., Mishra, V., Rana, A., Ahire, J.J. (2022). Riboswitch-mediated regulation of riboflavin biosynthesis genes in prokaryotes. 3 Biotech. https://doi.org/10.1007/s13205-022-03348-3
    Cited by 45 articles
  2. Kumar, V., Ahire, J.J., Taneja, N.K. (2023). Techno-Functional Assessment of Riboflavin-Enriched Yogurt-Based Fermented Milk Prepared by Supplementing Riboflavin-Producing Probiotic Strains of Lactiplantibacillus plantarum. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-022-1026-6
    Cited by 10 articles
  3. Kumar, V., Taneja, N.K., Ahire, J.J. (2023). Microencapsulation of riboflavin-producing Lactiplantibacillus plantarum MTCC 25432 and Evaluation of its Survival in Simulated Gastric and Intestinal Fluid. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-023-10115-0
    Cited by 5 articles
  4. Kumar, V., Taneja, N.K., Ahire, J.J. (2024). Advancing microbial food safety and hazard analysis through predictive mathematical modeling. The Microbe. https://doi.org/10.1016/j.microb.2024.100049
    Cited by 2 articles
  5. Ahire, J.J., Kumar, V., & Rohilla, A. (2023). Understanding Osteoporosis: Human Bone Density, Genetic Mechanisms, Gut Microbiota, and Future Prospects. Probiotics and Antimicrobial Proteins. https://doi.org/10.1007/s12602-023-10185-0
    Cited by 3 articles

Wael El-Sayed | Microbiology | Best Research Article Award

Prof Dr. Wael El-Sayed | Microbiology | Best Research Article Award

Professor, Ain Shams University, Egypt

Dr. Wael M. El-Sayed is a distinguished Professor of Toxicology and Physiology with over 30 years of experience in research, education, and mentorship. He has made significant contributions to the fields of toxicology, drug development, and molecular biology, particularly in understanding the therapeutic mechanisms of natural products. His academic journey has taken him from Cairo to Salt Lake City, and his work continues to impact the global scientific community.

Profile

Scopus

Strengths for the Award

  1. Extensive Research Experience:
    • Dr. El-Sayed has over 30 years of experience in physiology, toxicology, drug development, molecular biology, natural products, and tissue culture research. This extensive background demonstrates his deep knowledge and expertise in these fields.
  2. Diverse Research Interests:
    • His research spans a wide range of topics, including natural products, drug-drug interactions, chemoprotection strategies in cancer, antioxidants, and biochemical and molecular toxicology. This diversity reflects his ability to contribute to various research areas, which can be a significant advantage for a “Best Research Article Award.”
  3. High-Impact Publications:
    • Dr. El-Sayed has published research in reputable journals, such as Frontiers in Oncology and Journal of King Saud University – Science, which indicates the quality and relevance of his work. His recent studies on topics like the miRNome of hepatocellular carcinoma and potential COVID-19 inhibitors showcase his involvement in cutting-edge research.
  4. International Collaboration:
    • He has collaborated with researchers from different countries and institutions, including the University of Utah, USA, and King Faisal University, Saudi Arabia. This international exposure enriches his research perspectives and broadens the impact of his work.
  5. Recent and Relevant Publications:
    • The publication dates of his work, particularly in 2022 and 2023, indicate that Dr. El-Sayed is actively engaged in current research, which is crucial for winning an award for the best research article.

Areas for Improvement

  1. Focus on Breakthrough Research:
    • While Dr. El-Sayed’s research is diverse and impactful, the award committee might prioritize groundbreaking or highly innovative work. Emphasizing and furthering research that introduces novel concepts or significantly advances existing knowledge could strengthen his candidacy.
  2. Citation Impact and Recognition:
    • Although Dr. El-Sayed has published in high-quality journals, the impact of these publications, such as citation counts or recognition in the scientific community, could be further highlighted. Demonstrating the influence of his work on the field would reinforce his qualifications for the award.
  3. Enhanced Dissemination:
    • To increase the visibility and impact of his research, Dr. El-Sayed could focus on disseminating his findings through conferences, workshops, and broader media, enhancing the accessibility and application of his work beyond academic circles.

Education 🎓

Dr. El-Sayed earned his Ph.D. in Toxicology from Ain Shams University, Egypt, in collaboration with the College of Pharmacy, University of Utah, USA. His doctoral research focused on the “Mechanisms of therapeutic activities of Nigella Sativa against lipid peroxidation and hepatotoxicity in male albino rats.” Prior to this, he completed his M.Sc. in Physiology from Ain Shams University, where he explored the “Effect of Nigella Sativa on some physiological and biochemical parameters in male albino rats.” He also holds a B.Sc. in Science from Ain Shams University.

Experience 🧪

Dr. El-Sayed has held several key academic positions throughout his career. Since 2014, he has been a Professor at the Zoology Department, Faculty of Science, Ain Shams University, Cairo, Egypt. He previously served as an Associate Professor at the same department (2009-2014) and at the Biology Department, King Faisal University, Saudi Arabia (2007-2013). His early academic career includes his role as an Assistant Professor at Ain Shams University (2003-2009).

Research Interests 🔬

Dr. El-Sayed’s research spans a broad spectrum of scientific domains, including:

  • Natural products: Investigating therapeutic properties from plant and animal sources.
  • Drug-drug interactions: Understanding how drugs interact and their metabolic pathways.
  • Novel drug evaluation: Assessing the efficacy and safety of new pharmaceuticals.
  • Cancer chemoprotection: Developing strategies for cancer prevention and treatment.
  • Antioxidants: Exploring their role in health and disease.
  • Molecular toxicology: Studying the biochemical and molecular effects of toxins.

Awards 🏆

Dr. El-Sayed’s dedication to scientific research and education has earned him recognition in the academic community. His innovative work in toxicology and natural products has positioned him as a leader in his field, contributing to numerous advancements that have been acknowledged by peers and institutions worldwide.

Publications Top Notes 📚

Dr. El-Sayed has authored numerous impactful publications. Some of his recent notable works include:

miRNome of Child A hepatocellular carcinoma in Egyptian patientsFrontiers in Oncology, 2023. DOI: 10.3389/fonc.2023.1137585
Cited by multiple studies exploring hepatocellular carcinoma.

1,4,9,9-tetramethyloctahydro-4,7-(epoxymethano)azulen-5(1H)-one, a natural product as a potential inhibitor of COVID-19Journal of King Saud University – Science, 2023. DOI: 10.1016/j.jksus.2023.102628
Referenced in research on antiviral drug development.

Investigating the Antifertility Efficacy of Testosterone on Male and Female Albino MicePakistan Journal of Zoology, 2023. DOI: 10.17582/journal.pjz/20211107091104
Contributed to studies on reproductive health.

New Benzochromeno[2,3-d]pyrimidines and Benzochromenotriazolo[1,5-c]pyrimidines as Potential Inhibitors of Topoisomerase IIPolycyclic Aromatic Compounds, 2022. DOI: 10.1080/10406638.2021.2006247
Cited in cancer research for topoisomerase inhibitors.

Conclusion

Dr. Wael M. El-Sayed is a highly qualified candidate for the “Best Research Article Award,” given his extensive experience, diverse research interests, and recent high-impact publications. His work contributes significantly to the fields of toxicology, drug development, and natural products, making him a strong contender. However, to maximize his chances, he may benefit from emphasizing the novelty and broader impact of his research, as well as enhancing its visibility within the scientific community. Overall, his credentials and contributions align well with the criteria for the award, making him a suitable candidate.